DynaGen Inc. Signs Manufacturing and Distribution Agreement with Remel LP

Strategic Insights -

DynaGen Inc., a healthcare company founded in 1988, has announced a significant development in its diagnostic product portfolio with the signing of a manufacturing and distribution agreement with Remel LP. Under this agreement, Remel will have exclusive rights to manufacture and sell DynaGen's MycoAKT latex agglutination products in the United States, and semi-exclusive rights for the rest of the world. The MycoAKT tests are used for identifying mycobacterial species isolated in culture, providing a simple, rapid, and relatively inexpensive means to classify the mycobacteria as M. tuberculosis complex, M. avium complex, or M. kansasii.

Key Takeaways:

  • DynaGen Inc. has signed a manufacturing and distribution agreement with Remel LP, a privately held company based in Lenexa, Kan.
  • Remel has exclusive rights to manufacture and sell DynaGen's MycoAKT latex agglutination products in the United States, and semi-exclusive rights for the rest of the world.
  • The MycoAKT tests are used for identifying mycobacterial species isolated in culture, classifying them as M. tuberculosis complex, M. avium complex, or M. kansasii.
  • The agreement with Remel increases DynaGen's presence in the worldwide marketplace for tuberculosis diagnostic products.
  • DynaGen Inc. develops and markets diagnostic and therapeutic products for human and animal healthcare.
  • The company estimates that five million cultures for mycobacteria are performed annually in the United States.
  • The MycoAKT tests provide a rapid and relatively inexpensive means of classifying mycobacteria, which is important for prescribing appropriate drug therapy, especially for AIDS patients.

Statistics:

  • 5 million cultures for mycobacteria are performed annually in the United States.
  • The MycoAKT test provides a rapid and relatively inexpensive means of classifying mycobacteria (estimated cost not disclosed).
  • DynaGen Inc. was founded in 1988.
  • Remel LP is a privately held company based in Lenexa, Kan.

Sources:

  • "DynaGen Inc. Signs Manufacturing and Distribution Agreement with Remel LP" (Business Wire, Nov. 9, 1995)
  • "DynaGen Inc. Profile" ( BUSINESS WIRE, date not specified)